Acotec Scientific Holdings Limited (stock code 06669, “ACOTEC-B”) has announced that its board of directors will convene on 26 March 2026. The agenda includes:

• Reviewing and approving the audited consolidated results of ACOTEC-B and its subsidiaries for the financial year ended 31 December 2025.

• Deliberating on the declaration and payment of a final dividend, if any, for the period under review.

The meeting will be chaired by Executive Director and Chief Executive Officer Ms. Jing Li, who also serves as Chairperson of the Board. The current board comprises one executive director, three non-executive directors, and three independent non-executive directors.

The company plans to release its audited annual results to the market following board approval on the meeting date.